引用本文:[点击复制]
[点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 646次   下载 772 本文二维码信息
码上扫一扫!
α-干扰素与阿昔洛韦治疗儿童传染性单核细胞增多症疗效比较
熊寿贵,余更生
0
(1.广东省珠海市妇幼保健院,广东珠海 519000;2.重庆医科大学附属儿童医院,重庆 400014)
摘要:
目的:评价α-干扰素与阿昔洛韦治疗儿童传染性单核细胞增多症的临床疗效。方法:选取2013年1月至2014年12月我院收治的72例传染性单核细胞增多症患儿,随机分为α-干扰素组、阿昔洛韦组和对照组各24例。α-干扰素组给予肌肉注射α-干扰素,疗程5~7 d,<1岁患儿1~ 2 μg/(kg·d),>1岁患儿10 μg/d;阿昔洛韦组予以阿昔洛韦5 mg/kg,每8 h一次静脉滴注,疗程5~7 d,对照组患儿不采用任何抗病毒药物治疗,比较三组的临床疗效。结果:α-干扰素组的退热时间(3.63±1.77)d,颈部淋巴结肿大消退时间(5.25±1.28)d,肝脾肿大恢复时间(5.88±1.36)d,均较阿昔洛韦组及对照组明显缩短(P<0.05),不良反应发生率低且轻(12.5%)。结论:α-干扰素治疗传染性单核细胞增多症疗效及安全性要优于阿昔洛韦,有很好的临床应用价值。
关键词:  儿童  传染性单核细胞增多症  阿昔洛韦  α-干扰素
DOI:doi:10.13407/j.cnki.jpp.1672-108X.2016.01.012
基金项目:
The Ecffect of α-Interferon and Aciclovir Analysis of Children with Infectious Mononucleosis
Xiong Shougui1, Yu Gengsheng2
(1. Zhuhai Maternity and Child Health Hospital, Guangdong Zhuhai 519000, China; 2. Children/s Hospital of Chongqing Medical University, Chongqing 400014, China)
Abstract:
Objective: To evaluate the clinical effect of α-interferon and aciclovir on treating infectious mononucleosis (IM). Methods: Seventy-two children with IM were divided into three groups at random with twenty-four childrens in every group: two groups treated with α-interferon and acyclovir respectively, and the control group treated without any anti-viral drugs. The effeccts of α-interferon and aciclovir in treating IM were analyzed. Results: The recovery duration of fever, enlarged neck lymph nodes and enlarged liver and spleen of the group with α-interferon were shorter than the group with aciclovir significantly (P<0.05). The risk of adverse reactions of α-interferon in treating IM was little (12.5%) and not serious. Conclusion: α-Interferon was better and more safty than acyclovir, and has important clinical value in treating infectious mononucleosis(IM).
Key words:  Children  Infectious mononucleosis  α-Interferon  Aciclovir

用微信扫一扫

用微信扫一扫